ckit Search Results


94
AutoMate Scientific Inc footshocks
Footshocks, supplied by AutoMate Scientific Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ckit/Pedestal/pmc04162870-48-112-90
Average 94 stars, based on 1 article reviews
footshocks - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

92
Addgene inc patrick salmon
Patrick Salmon, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ckit/pCLXEBR-pTF-cKit+(Plasmid+%23114293)/pm38384854-179-9-11
Average 92 stars, based on 1 article reviews
patrick salmon - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

90
BPS Bioscience c kit
C Kit, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ckit/cKIT+Assay+Kit/pmc04832243-173-14-20
Average 90 stars, based on 1 article reviews
c kit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

86
10X Genomics 10x genomics ckit data
a-b) UMAP plots of (a) wild- type (left) and (b) ThPOK−/− (right) C-GMP myeloid progenitors (Lin-, Kit+, Sca1-, CD34hi, CD16/32+/−, gated as in Extended data Fig.5b). Shown cell populations were defined based on reference alignment to a prior curated murine <t>cKit+</t> CITE-Seq dataset (Extended data Fig.5a). Overlaid arrows indicate predicted RNA velocities derived from spliced versus unspliced scRNA-Seq reads. Areas with the greatest predicted observed trajectory differences are denoted by purple or red circles. c) Number of differentially expressed genes (DEGs) that are up- or downregulated in ThPOK−/− versus wild-type cells by cellHarmony analysis for indicated cell populations. d) cellHarmony organized heatmap of dynamically regulated DEGs in ThPOK−/− and wt for the most frequency detected cell populations (n=1,685 genes, fold > 1.1 and empirical Bayes moderated t-test p<0.05, FDR corrected). Yellow = upregulated gene, blue = downregulated gene. Genes noted in the text are called out to the right of the heatmap. e) Relative statistical enrichment (GO-Elite Z-score) of ThPOK−/− versus wild-type up-regulated genes against all prior defined hematopoietic differentiation markers17, indicates altered differentiation programs in ThPOK−/− mice, for lineage priming (top), lineage specification (middle) and neutrophil commitment (bottom). f) Gene Ontology enrichment analysis (GO-Elite) of down- (right) and up-regulated genes in ThPOK−/− versus wt MDP cells, with example terms highlighted.
10x Genomics Ckit Data, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ckit/10x+ckit+data+genomics/pmc10792516-196-5-5
Average 86 stars, based on 1 article reviews
10x genomics ckit data - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
Becton Dickinson ckit
(A) The Brca1CC allele was generated using the indicated sgRNA sequence that targeted exon 13. DNA and amino acids deleted are shown (red). Below, electropherogram showing DNA sequences of Brca1+/+ and Brca1CC/CC mice, deleted base pairs (box) and deletion location (arrow) are indicated. (B) MEFs with the indicated genotypes were assessed for Brca1 protein expression by Western blotting. (C) MEFs with the indicated genotypes were assessed for RAD51 IRIF by immunofluorescence (IF). Nuclei with >5 foci were considered positive. Mean and S.E.M. are shown, n=3. Representative images, scale bar is 10 μm. (D) Summary of live pups born as well as live embryos at E16.5 generated from Brca1+/CC x Brca1+/CC intercross. (E) Representative photographs of E16.5 embryos, scale bar 0.5 cm; and 3-week old littermates, scale bar 2 cm. Hypopigmented fur area is indicated with an arrow. (F) Weights of individual mice at 3–4 weeks of age. (G) White blood cell (WBC), red blood cell (RBC) numbers from peripheral blood, and (H) mononuclear bone marrow (BM) cell numbers were measured in 3–4-week-old littermates with the indicated genotypes. Inset, representative H&E staining of BM, scale bar 100 μm. (I) Total number of long-term hematopoietic stem cells (LT-HSC) (Linlow; <t>cKit+;</t> <t>Sca+;</t> CD150+; CD48−; CD34−) analyzed by FACS in 3–4-week-old mice. See Fig. S1 for more information. (J) Representative H&E staining of testes and ovaries, scale bar 100 μm. (K) Representative images of T-ALL from a Brca1CC/CC mouse. H&E staining of thymic tumor and CD3+ staining of tumor cell infiltrates from the same mouse, scale bar 100 μm. Summary of Brca1CC/CC lifespans (days) and cause of death when known (inset). *p < 0.05 **p < 0.01, *** p < 0.001 (unpaired t-test).
Ckit, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ckit/ckit+antibody/pmc07418109-447-42-44
Average 90 stars, based on 1 article reviews
ckit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Becton Dickinson ckit-apc_ch7
(A) The Brca1CC allele was generated using the indicated sgRNA sequence that targeted exon 13. DNA and amino acids deleted are shown (red). Below, electropherogram showing DNA sequences of Brca1+/+ and Brca1CC/CC mice, deleted base pairs (box) and deletion location (arrow) are indicated. (B) MEFs with the indicated genotypes were assessed for Brca1 protein expression by Western blotting. (C) MEFs with the indicated genotypes were assessed for RAD51 IRIF by immunofluorescence (IF). Nuclei with >5 foci were considered positive. Mean and S.E.M. are shown, n=3. Representative images, scale bar is 10 μm. (D) Summary of live pups born as well as live embryos at E16.5 generated from Brca1+/CC x Brca1+/CC intercross. (E) Representative photographs of E16.5 embryos, scale bar 0.5 cm; and 3-week old littermates, scale bar 2 cm. Hypopigmented fur area is indicated with an arrow. (F) Weights of individual mice at 3–4 weeks of age. (G) White blood cell (WBC), red blood cell (RBC) numbers from peripheral blood, and (H) mononuclear bone marrow (BM) cell numbers were measured in 3–4-week-old littermates with the indicated genotypes. Inset, representative H&E staining of BM, scale bar 100 μm. (I) Total number of long-term hematopoietic stem cells (LT-HSC) (Linlow; <t>cKit+;</t> <t>Sca+;</t> CD150+; CD48−; CD34−) analyzed by FACS in 3–4-week-old mice. See Fig. S1 for more information. (J) Representative H&E staining of testes and ovaries, scale bar 100 μm. (K) Representative images of T-ALL from a Brca1CC/CC mouse. H&E staining of thymic tumor and CD3+ staining of tumor cell infiltrates from the same mouse, scale bar 100 μm. Summary of Brca1CC/CC lifespans (days) and cause of death when known (inset). *p < 0.05 **p < 0.01, *** p < 0.001 (unpaired t-test).
Ckit Apc Ch7, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ckit/ckit+apc+ch7+antibody/pmc03026610-417-8-10
Average 90 stars, based on 1 article reviews
ckit-apc_ch7 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
ProQinase GmbH n-terminal gst-tagged recombinant human kit, amino acid t544-v976
(A) The Brca1CC allele was generated using the indicated sgRNA sequence that targeted exon 13. DNA and amino acids deleted are shown (red). Below, electropherogram showing DNA sequences of Brca1+/+ and Brca1CC/CC mice, deleted base pairs (box) and deletion location (arrow) are indicated. (B) MEFs with the indicated genotypes were assessed for Brca1 protein expression by Western blotting. (C) MEFs with the indicated genotypes were assessed for RAD51 IRIF by immunofluorescence (IF). Nuclei with >5 foci were considered positive. Mean and S.E.M. are shown, n=3. Representative images, scale bar is 10 μm. (D) Summary of live pups born as well as live embryos at E16.5 generated from Brca1+/CC x Brca1+/CC intercross. (E) Representative photographs of E16.5 embryos, scale bar 0.5 cm; and 3-week old littermates, scale bar 2 cm. Hypopigmented fur area is indicated with an arrow. (F) Weights of individual mice at 3–4 weeks of age. (G) White blood cell (WBC), red blood cell (RBC) numbers from peripheral blood, and (H) mononuclear bone marrow (BM) cell numbers were measured in 3–4-week-old littermates with the indicated genotypes. Inset, representative H&E staining of BM, scale bar 100 μm. (I) Total number of long-term hematopoietic stem cells (LT-HSC) (Linlow; <t>cKit+;</t> <t>Sca+;</t> CD150+; CD48−; CD34−) analyzed by FACS in 3–4-week-old mice. See Fig. S1 for more information. (J) Representative H&E staining of testes and ovaries, scale bar 100 μm. (K) Representative images of T-ALL from a Brca1CC/CC mouse. H&E staining of thymic tumor and CD3+ staining of tumor cell infiltrates from the same mouse, scale bar 100 μm. Summary of Brca1CC/CC lifespans (days) and cause of death when known (inset). *p < 0.05 **p < 0.01, *** p < 0.001 (unpaired t-test).
N Terminal Gst Tagged Recombinant Human Kit, Amino Acid T544 V976, supplied by ProQinase GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ckit/c+kit+ckit+residues+t544+v976/pmc03906526-34-3-23
Average 90 stars, based on 1 article reviews
n-terminal gst-tagged recombinant human kit, amino acid t544-v976 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Linaris GmbH primary antibodies against c- kit
(A) The Brca1CC allele was generated using the indicated sgRNA sequence that targeted exon 13. DNA and amino acids deleted are shown (red). Below, electropherogram showing DNA sequences of Brca1+/+ and Brca1CC/CC mice, deleted base pairs (box) and deletion location (arrow) are indicated. (B) MEFs with the indicated genotypes were assessed for Brca1 protein expression by Western blotting. (C) MEFs with the indicated genotypes were assessed for RAD51 IRIF by immunofluorescence (IF). Nuclei with >5 foci were considered positive. Mean and S.E.M. are shown, n=3. Representative images, scale bar is 10 μm. (D) Summary of live pups born as well as live embryos at E16.5 generated from Brca1+/CC x Brca1+/CC intercross. (E) Representative photographs of E16.5 embryos, scale bar 0.5 cm; and 3-week old littermates, scale bar 2 cm. Hypopigmented fur area is indicated with an arrow. (F) Weights of individual mice at 3–4 weeks of age. (G) White blood cell (WBC), red blood cell (RBC) numbers from peripheral blood, and (H) mononuclear bone marrow (BM) cell numbers were measured in 3–4-week-old littermates with the indicated genotypes. Inset, representative H&E staining of BM, scale bar 100 μm. (I) Total number of long-term hematopoietic stem cells (LT-HSC) (Linlow; <t>cKit+;</t> <t>Sca+;</t> CD150+; CD48−; CD34−) analyzed by FACS in 3–4-week-old mice. See Fig. S1 for more information. (J) Representative H&E staining of testes and ovaries, scale bar 100 μm. (K) Representative images of T-ALL from a Brca1CC/CC mouse. H&E staining of thymic tumor and CD3+ staining of tumor cell infiltrates from the same mouse, scale bar 100 μm. Summary of Brca1CC/CC lifespans (days) and cause of death when known (inset). *p < 0.05 **p < 0.01, *** p < 0.001 (unpaired t-test).
Primary Antibodies Against C Kit, supplied by Linaris GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ckit/rat+anti+ckit+antibody/pm40159839-118-6-18
Average 90 stars, based on 1 article reviews
primary antibodies against c- kit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc apc-efluor780-conjugated ckit antibody
(A) The Brca1CC allele was generated using the indicated sgRNA sequence that targeted exon 13. DNA and amino acids deleted are shown (red). Below, electropherogram showing DNA sequences of Brca1+/+ and Brca1CC/CC mice, deleted base pairs (box) and deletion location (arrow) are indicated. (B) MEFs with the indicated genotypes were assessed for Brca1 protein expression by Western blotting. (C) MEFs with the indicated genotypes were assessed for RAD51 IRIF by immunofluorescence (IF). Nuclei with >5 foci were considered positive. Mean and S.E.M. are shown, n=3. Representative images, scale bar is 10 μm. (D) Summary of live pups born as well as live embryos at E16.5 generated from Brca1+/CC x Brca1+/CC intercross. (E) Representative photographs of E16.5 embryos, scale bar 0.5 cm; and 3-week old littermates, scale bar 2 cm. Hypopigmented fur area is indicated with an arrow. (F) Weights of individual mice at 3–4 weeks of age. (G) White blood cell (WBC), red blood cell (RBC) numbers from peripheral blood, and (H) mononuclear bone marrow (BM) cell numbers were measured in 3–4-week-old littermates with the indicated genotypes. Inset, representative H&E staining of BM, scale bar 100 μm. (I) Total number of long-term hematopoietic stem cells (LT-HSC) (Linlow; <t>cKit+;</t> <t>Sca+;</t> CD150+; CD48−; CD34−) analyzed by FACS in 3–4-week-old mice. See Fig. S1 for more information. (J) Representative H&E staining of testes and ovaries, scale bar 100 μm. (K) Representative images of T-ALL from a Brca1CC/CC mouse. H&E staining of thymic tumor and CD3+ staining of tumor cell infiltrates from the same mouse, scale bar 100 μm. Summary of Brca1CC/CC lifespans (days) and cause of death when known (inset). *p < 0.05 **p < 0.01, *** p < 0.001 (unpaired t-test).
Apc Efluor780 Conjugated Ckit Antibody, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ckit/apc+efluor780+conjugated+ckit+antibody/pmc10703894-306-6-41
Average 90 stars, based on 1 article reviews
apc-efluor780-conjugated ckit antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Sony anti-cd127 (il-7rα)-pe-cyanine7
Leukocytes were isolated from Tbx21 +/+ (WT; blue) and Tbx21 -/- (red) bone marrow and iNK, mNK1 and mNK2 cell subsets were screened by flow cytometry for differentially expressed proteins. Proteins examined were selected based on differential expression of their transcripts between Tbx21 +/+ and Tbx21 -/- in the RNASeq screen. Representative histograms and summary graphs for (a) CCR2, (b) CD49a, (c) CD62L, (d) CD69, (e) <t>CD127,</t> (f) cKit, (g) CXCR6, (h) CX3CR1, and (i) S1PR5 are shown. n = 6 mice per group, means and SD are shown. Significance was determined using two-sample, one-tailed t tests with Holm-Sidak correction. * p < 0.05, ** p < 0.01, *** p < 0.001.
Anti Cd127 (Il 7rα) Pe Cyanine7, supplied by Sony, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ckit/anti+cd117++ckit++apc+cyanine7/bio_rxiv__583575-148-139-143
Average 90 stars, based on 1 article reviews
anti-cd127 (il-7rα)-pe-cyanine7 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Mastocytosis Society ckit
Leukocytes were isolated from Tbx21 +/+ (WT; blue) and Tbx21 -/- (red) bone marrow and iNK, mNK1 and mNK2 cell subsets were screened by flow cytometry for differentially expressed proteins. Proteins examined were selected based on differential expression of their transcripts between Tbx21 +/+ and Tbx21 -/- in the RNASeq screen. Representative histograms and summary graphs for (a) CCR2, (b) CD49a, (c) CD62L, (d) CD69, (e) <t>CD127,</t> (f) cKit, (g) CXCR6, (h) CX3CR1, and (i) S1PR5 are shown. n = 6 mice per group, means and SD are shown. Significance was determined using two-sample, one-tailed t tests with Holm-Sidak correction. * p < 0.05, ** p < 0.01, *** p < 0.001.
Ckit, supplied by Mastocytosis Society, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ckit/ckit/pmc05932183-39-3-10
Average 90 stars, based on 1 article reviews
ckit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Phase Genomics glycine proximetatmhi-ckit
Leukocytes were isolated from Tbx21 +/+ (WT; blue) and Tbx21 -/- (red) bone marrow and iNK, mNK1 and mNK2 cell subsets were screened by flow cytometry for differentially expressed proteins. Proteins examined were selected based on differential expression of their transcripts between Tbx21 +/+ and Tbx21 -/- in the RNASeq screen. Representative histograms and summary graphs for (a) CCR2, (b) CD49a, (c) CD62L, (d) CD69, (e) <t>CD127,</t> (f) cKit, (g) CXCR6, (h) CX3CR1, and (i) S1PR5 are shown. n = 6 mice per group, means and SD are shown. Significance was determined using two-sample, one-tailed t tests with Holm-Sidak correction. * p < 0.05, ** p < 0.01, *** p < 0.001.
Glycine Proximetatmhi Ckit, supplied by Phase Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ckit/glycine+proximetatmhi+ckit/pm37996432-247-0-2
Average 90 stars, based on 1 article reviews
glycine proximetatmhi-ckit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


a-b) UMAP plots of (a) wild- type (left) and (b) ThPOK−/− (right) C-GMP myeloid progenitors (Lin-, Kit+, Sca1-, CD34hi, CD16/32+/−, gated as in Extended data Fig.5b). Shown cell populations were defined based on reference alignment to a prior curated murine cKit+ CITE-Seq dataset (Extended data Fig.5a). Overlaid arrows indicate predicted RNA velocities derived from spliced versus unspliced scRNA-Seq reads. Areas with the greatest predicted observed trajectory differences are denoted by purple or red circles. c) Number of differentially expressed genes (DEGs) that are up- or downregulated in ThPOK−/− versus wild-type cells by cellHarmony analysis for indicated cell populations. d) cellHarmony organized heatmap of dynamically regulated DEGs in ThPOK−/− and wt for the most frequency detected cell populations (n=1,685 genes, fold > 1.1 and empirical Bayes moderated t-test p<0.05, FDR corrected). Yellow = upregulated gene, blue = downregulated gene. Genes noted in the text are called out to the right of the heatmap. e) Relative statistical enrichment (GO-Elite Z-score) of ThPOK−/− versus wild-type up-regulated genes against all prior defined hematopoietic differentiation markers17, indicates altered differentiation programs in ThPOK−/− mice, for lineage priming (top), lineage specification (middle) and neutrophil commitment (bottom). f) Gene Ontology enrichment analysis (GO-Elite) of down- (right) and up-regulated genes in ThPOK−/− versus wt MDP cells, with example terms highlighted.

Journal: Nature immunology

Article Title: ThPOK is a critical multifaceted regulator of myeloid lineage development

doi: 10.1038/s41590-023-01549-3

Figure Lengend Snippet: a-b) UMAP plots of (a) wild- type (left) and (b) ThPOK−/− (right) C-GMP myeloid progenitors (Lin-, Kit+, Sca1-, CD34hi, CD16/32+/−, gated as in Extended data Fig.5b). Shown cell populations were defined based on reference alignment to a prior curated murine cKit+ CITE-Seq dataset (Extended data Fig.5a). Overlaid arrows indicate predicted RNA velocities derived from spliced versus unspliced scRNA-Seq reads. Areas with the greatest predicted observed trajectory differences are denoted by purple or red circles. c) Number of differentially expressed genes (DEGs) that are up- or downregulated in ThPOK−/− versus wild-type cells by cellHarmony analysis for indicated cell populations. d) cellHarmony organized heatmap of dynamically regulated DEGs in ThPOK−/− and wt for the most frequency detected cell populations (n=1,685 genes, fold > 1.1 and empirical Bayes moderated t-test p<0.05, FDR corrected). Yellow = upregulated gene, blue = downregulated gene. Genes noted in the text are called out to the right of the heatmap. e) Relative statistical enrichment (GO-Elite Z-score) of ThPOK−/− versus wild-type up-regulated genes against all prior defined hematopoietic differentiation markers17, indicates altered differentiation programs in ThPOK−/− mice, for lineage priming (top), lineage specification (middle) and neutrophil commitment (bottom). f) Gene Ontology enrichment analysis (GO-Elite) of down- (right) and up-regulated genes in ThPOK−/− versus wt MDP cells, with example terms highlighted.

Article Snippet: After projecting labels from the 10x Genomics cKit data onto the Fluidigm transcriptome of WT cells ( – ), we observed a progressive increase in alternative splicing in proNeu-1 through preNeu-1 stages.

Techniques: Derivative Assay

a) FACS analysis of cKit, Sca1, CD16/32 and CD34 expression by gated total lineage negative (Lin-) or Lin- cKit+ Sca1- BM cells, as indicated. CMP, GMP, MEP and CD34lo gates are shown in right panels. b) Plots showing frequency of Lin-Sca-cKit+ cells in total BM and of CMP, GMP, MEP and CD34lo subsets in gated cKit+ Sca1- Lin- BM cells from ThPOK-deficient or WT mice (same gates as panel a) (n = 5 biologically independent animals per genotype). Error bars represent standard deviations (centre refers to mean). Significant differences between ThPOK−/− and WT mice were determined by two sided unpaired T test with Welch’s correction, and indicated by asterisks (* p < 0.05; ** p < 0.01; *** p < 0.001). c) FACS comparison of CD11b, CD115, Ly6c, and Ly6g expression by gated cGMP (conventional GMP) (grey histograms) and atypical c-Kit+ CD34lo CD16hi Lin- (green histograms) BM subsets, from ThPOK-deficient mice. d) FACS analysis of CD11b, Ly6g, Vcam1, CD115, Ly6c, CD16/32, cKit and CD34 expression by indicated gated BM subsets. Gates for preNeu1-3 (preN1-3), proNeu1/2 and other precursor populations are shown. e) Plots showing frequency (left panels) or cell number (right panels) of indicated gated precursor populations in ThPOK-deficient or WT mice (same mice as panel d). Data are presented as mean values +/− SEM. Significant differences between ThPOK−/− and WT mice were determined by two sided unpaired T test, and indicated by asterisks (* p < 0.05; ** p < 0.01; *** p < 0.001). n = 5 biologically independent animals.

Journal: Nature immunology

Article Title: ThPOK is a critical multifaceted regulator of myeloid lineage development

doi: 10.1038/s41590-023-01549-3

Figure Lengend Snippet: a) FACS analysis of cKit, Sca1, CD16/32 and CD34 expression by gated total lineage negative (Lin-) or Lin- cKit+ Sca1- BM cells, as indicated. CMP, GMP, MEP and CD34lo gates are shown in right panels. b) Plots showing frequency of Lin-Sca-cKit+ cells in total BM and of CMP, GMP, MEP and CD34lo subsets in gated cKit+ Sca1- Lin- BM cells from ThPOK-deficient or WT mice (same gates as panel a) (n = 5 biologically independent animals per genotype). Error bars represent standard deviations (centre refers to mean). Significant differences between ThPOK−/− and WT mice were determined by two sided unpaired T test with Welch’s correction, and indicated by asterisks (* p < 0.05; ** p < 0.01; *** p < 0.001). c) FACS comparison of CD11b, CD115, Ly6c, and Ly6g expression by gated cGMP (conventional GMP) (grey histograms) and atypical c-Kit+ CD34lo CD16hi Lin- (green histograms) BM subsets, from ThPOK-deficient mice. d) FACS analysis of CD11b, Ly6g, Vcam1, CD115, Ly6c, CD16/32, cKit and CD34 expression by indicated gated BM subsets. Gates for preNeu1-3 (preN1-3), proNeu1/2 and other precursor populations are shown. e) Plots showing frequency (left panels) or cell number (right panels) of indicated gated precursor populations in ThPOK-deficient or WT mice (same mice as panel d). Data are presented as mean values +/− SEM. Significant differences between ThPOK−/− and WT mice were determined by two sided unpaired T test, and indicated by asterisks (* p < 0.05; ** p < 0.01; *** p < 0.001). n = 5 biologically independent animals.

Article Snippet: After projecting labels from the 10x Genomics cKit data onto the Fluidigm transcriptome of WT cells ( – ), we observed a progressive increase in alternative splicing in proNeu-1 through preNeu-1 stages.

Techniques: Expressing, Comparison

a) Bar graphs showing absolute cell numbers for CMP, GMP, MEP and CD34lo subsets among gated cKit+ Sca1- Lin- BM cells from ThPOK-deficient or WT mice (same mice as Fig. 2 A, ​,B)B) (n = 5 independent animals per genotype). Error bars represent SEM. Significant differences between ThPOK−/− and WT mice were determined by two-sided unpaired T test with Welch’s correction, and indicated by asterisks (* p < 0.05; ** p < 0.01; *** p < 0.001). b) FACS analysis of CD135 and CD115 expression by gated CMPs from WT and ThPOK−/− mice (left panels). Bar graph at right shows % of indicated gated subsets (n = 5 independent animals per genotype). c) FACS analysis of CD11b, CD115, Ly6c, and Ly6g expression by gated cGMP (conventional GMP) (grey histograms) and c-Kit+ CD34lo CD16hi Lin- (green histograms) BM subsets from WT mice. d) FACS analysis of CD16/32 and CD34 expression by gated Lin- c-Kit+ Sca1- BM cells from ThPOPK+/− mice. CMP, GMP, MEP and CD34lo subsets are marked. e) CFU assay of FACS-sorted Lin- BM cells, from indicated WT or ThPOK-deficient mice. Error bars represent SEM. Significant differences between ThPOK−/− and WT mice were determined by two-sided multiple multiple unpaired T with Welch’s correction, and indicated by asterisks (* p < 0.05; ** p < 0.01; *** p < 0.001). Note that ThPOK−/− Lin- progenitors exhibited a substantial (** p < 0.01) increase in CFU-GM myeloid colony production even after secondary plating. f) FACS analysis of CD11b, Thy1, CD41 and Ter119 lineage marker expression by WT and ThPOK-deficient cells after secondary CFU assay (same experiment as in panel d).

Journal: Nature immunology

Article Title: ThPOK is a critical multifaceted regulator of myeloid lineage development

doi: 10.1038/s41590-023-01549-3

Figure Lengend Snippet: a) Bar graphs showing absolute cell numbers for CMP, GMP, MEP and CD34lo subsets among gated cKit+ Sca1- Lin- BM cells from ThPOK-deficient or WT mice (same mice as Fig. 2 A, ​,B)B) (n = 5 independent animals per genotype). Error bars represent SEM. Significant differences between ThPOK−/− and WT mice were determined by two-sided unpaired T test with Welch’s correction, and indicated by asterisks (* p < 0.05; ** p < 0.01; *** p < 0.001). b) FACS analysis of CD135 and CD115 expression by gated CMPs from WT and ThPOK−/− mice (left panels). Bar graph at right shows % of indicated gated subsets (n = 5 independent animals per genotype). c) FACS analysis of CD11b, CD115, Ly6c, and Ly6g expression by gated cGMP (conventional GMP) (grey histograms) and c-Kit+ CD34lo CD16hi Lin- (green histograms) BM subsets from WT mice. d) FACS analysis of CD16/32 and CD34 expression by gated Lin- c-Kit+ Sca1- BM cells from ThPOPK+/− mice. CMP, GMP, MEP and CD34lo subsets are marked. e) CFU assay of FACS-sorted Lin- BM cells, from indicated WT or ThPOK-deficient mice. Error bars represent SEM. Significant differences between ThPOK−/− and WT mice were determined by two-sided multiple multiple unpaired T with Welch’s correction, and indicated by asterisks (* p < 0.05; ** p < 0.01; *** p < 0.001). Note that ThPOK−/− Lin- progenitors exhibited a substantial (** p < 0.01) increase in CFU-GM myeloid colony production even after secondary plating. f) FACS analysis of CD11b, Thy1, CD41 and Ter119 lineage marker expression by WT and ThPOK-deficient cells after secondary CFU assay (same experiment as in panel d).

Article Snippet: After projecting labels from the 10x Genomics cKit data onto the Fluidigm transcriptome of WT cells ( – ), we observed a progressive increase in alternative splicing in proNeu-1 through preNeu-1 stages.

Techniques: Expressing, Colony-forming Unit Assay, Marker

a) UMAP plot of curated cKit+ progenitor scRNA-Seq cell populations that serves as the reference for cellHarmony alignment analyses in these studies (see Methods), b) Flow cytometry selection of c-Kit+ BM C-GMP progenitors (gated cells denoted in blue). c) Unsupervised clustering UMAP plot of ~26,000 combined C-GMP CITE-Seq captured mRNA profiles (WT and ThPOK−/−) following analysis with the software ICGS2. Indicated cell-population labels are those automatically assigned by ICGS2 (AltAnalyze BioMarker database). d) UMAP plot of all WT and ThPOK−/− cells from panel c aligned to the reference described in panel a. e) UMAP plot from panel d showing the expression levels of ThPOK mRNA in the wild-type CITE-Seq populations. f) Cell-population percentage of distinct BM progenitor populations detected by CITE-Seq from WT and ThPOK−/− mice. g–h) Heatmap of relative normalized (TotalVI) CITE-Seq antibody derived-tag (ADT) intensities for cellHarmony cKit+ aligned cell populations. Panels (g) and (h) displays cells from WT and ThPOK−/− BM progenitors, respectively. i–p) Gene Ontology enrichment analyses from the software GO-Elite, for each of the indicated cell population differential expression analysis comparisons (all ThPOK−/− vs. WT).

Journal: Nature immunology

Article Title: ThPOK is a critical multifaceted regulator of myeloid lineage development

doi: 10.1038/s41590-023-01549-3

Figure Lengend Snippet: a) UMAP plot of curated cKit+ progenitor scRNA-Seq cell populations that serves as the reference for cellHarmony alignment analyses in these studies (see Methods), b) Flow cytometry selection of c-Kit+ BM C-GMP progenitors (gated cells denoted in blue). c) Unsupervised clustering UMAP plot of ~26,000 combined C-GMP CITE-Seq captured mRNA profiles (WT and ThPOK−/−) following analysis with the software ICGS2. Indicated cell-population labels are those automatically assigned by ICGS2 (AltAnalyze BioMarker database). d) UMAP plot of all WT and ThPOK−/− cells from panel c aligned to the reference described in panel a. e) UMAP plot from panel d showing the expression levels of ThPOK mRNA in the wild-type CITE-Seq populations. f) Cell-population percentage of distinct BM progenitor populations detected by CITE-Seq from WT and ThPOK−/− mice. g–h) Heatmap of relative normalized (TotalVI) CITE-Seq antibody derived-tag (ADT) intensities for cellHarmony cKit+ aligned cell populations. Panels (g) and (h) displays cells from WT and ThPOK−/− BM progenitors, respectively. i–p) Gene Ontology enrichment analyses from the software GO-Elite, for each of the indicated cell population differential expression analysis comparisons (all ThPOK−/− vs. WT).

Article Snippet: After projecting labels from the 10x Genomics cKit data onto the Fluidigm transcriptome of WT cells ( – ), we observed a progressive increase in alternative splicing in proNeu-1 through preNeu-1 stages.

Techniques: Flow Cytometry, Selection, Software, Biomarker Discovery, Expressing, Derivative Assay, Quantitative Proteomics

(a–b) UMAP plot of single-cell Fluidigm RNA-Seq analysis of prior profiled (a) wild-type hematopoietic progenitors and (b) Ly6c-ThPOK−/− GMPs aligned to cKit+ CITE-Seq. Consistent alignment of cell populations in the UMAP space indicates a lack of apparent batch effects. c) Gene Ontology enrichment analysis of ThPOK−/− dependent alternative splicing events in proNeu-1 cells, for splicing events with the opposite pattern of exon inclusion in proNeu-1 versus MultiLin (discordant = more immature splicing) or (d) with the same pattern (concordant = promoting neutrophil specification associated splicing). (e‒f) Validation of deregulated gene expression in ThPOK−/− versus WT progenitors for important transcripts as observed in CITE seq data: e) qRTPCR analyses of indicated flow-sorted progenitors (pooled from 4 mice/genotype) for monocyte/DC genes (Irf8, Zeb2, Runx1), granulocyte lineage genes (Cebpe, Pde4d, Cd63 and Nkg7) and RNA binding protein genes (Ddx3x and Srsf5). The experiment was repeated 3 times independently with similar results. f) Expression ratio of Hmga1 alternate transcript versus reference transcript in indicated progenitor populations (pooled from 4 mice/genotype). g) Representative confocal micrographs of EZH2 protein (top), DAPI (middle), and H3K27Me3 (bottom) staining in indicated subsets. Each experiment was reproduced twice and significant differences between ThPOK−/− and WT mice were determined by two-sided unpaired T test with Welch’s correction, and indicated by asterisks (* p < 0.05; ** p < 0.01; *** p < 0.001). h) Heat maps showing relative mRNA expression of indicated genes in WT progenitors (left panel), or in ThPOK−/− versus WT progenitor subsets (right panel) for genes that are relatively up-regulated in any ThPOK−/− progenitor population and that are known Ezh2 targets in WT immune cells by ChIP-seq (GSE181873). Note that in WT mice most of these genes show marked stage-specific regulation.

Journal: Nature immunology

Article Title: ThPOK is a critical multifaceted regulator of myeloid lineage development

doi: 10.1038/s41590-023-01549-3

Figure Lengend Snippet: (a–b) UMAP plot of single-cell Fluidigm RNA-Seq analysis of prior profiled (a) wild-type hematopoietic progenitors and (b) Ly6c-ThPOK−/− GMPs aligned to cKit+ CITE-Seq. Consistent alignment of cell populations in the UMAP space indicates a lack of apparent batch effects. c) Gene Ontology enrichment analysis of ThPOK−/− dependent alternative splicing events in proNeu-1 cells, for splicing events with the opposite pattern of exon inclusion in proNeu-1 versus MultiLin (discordant = more immature splicing) or (d) with the same pattern (concordant = promoting neutrophil specification associated splicing). (e‒f) Validation of deregulated gene expression in ThPOK−/− versus WT progenitors for important transcripts as observed in CITE seq data: e) qRTPCR analyses of indicated flow-sorted progenitors (pooled from 4 mice/genotype) for monocyte/DC genes (Irf8, Zeb2, Runx1), granulocyte lineage genes (Cebpe, Pde4d, Cd63 and Nkg7) and RNA binding protein genes (Ddx3x and Srsf5). The experiment was repeated 3 times independently with similar results. f) Expression ratio of Hmga1 alternate transcript versus reference transcript in indicated progenitor populations (pooled from 4 mice/genotype). g) Representative confocal micrographs of EZH2 protein (top), DAPI (middle), and H3K27Me3 (bottom) staining in indicated subsets. Each experiment was reproduced twice and significant differences between ThPOK−/− and WT mice were determined by two-sided unpaired T test with Welch’s correction, and indicated by asterisks (* p < 0.05; ** p < 0.01; *** p < 0.001). h) Heat maps showing relative mRNA expression of indicated genes in WT progenitors (left panel), or in ThPOK−/− versus WT progenitor subsets (right panel) for genes that are relatively up-regulated in any ThPOK−/− progenitor population and that are known Ezh2 targets in WT immune cells by ChIP-seq (GSE181873). Note that in WT mice most of these genes show marked stage-specific regulation.

Article Snippet: After projecting labels from the 10x Genomics cKit data onto the Fluidigm transcriptome of WT cells ( – ), we observed a progressive increase in alternative splicing in proNeu-1 through preNeu-1 stages.

Techniques: RNA Sequencing, Alternative Splicing, Biomarker Discovery, Gene Expression, RNA Binding Assay, Expressing, Staining, ChIP-sequencing

(A) The Brca1CC allele was generated using the indicated sgRNA sequence that targeted exon 13. DNA and amino acids deleted are shown (red). Below, electropherogram showing DNA sequences of Brca1+/+ and Brca1CC/CC mice, deleted base pairs (box) and deletion location (arrow) are indicated. (B) MEFs with the indicated genotypes were assessed for Brca1 protein expression by Western blotting. (C) MEFs with the indicated genotypes were assessed for RAD51 IRIF by immunofluorescence (IF). Nuclei with >5 foci were considered positive. Mean and S.E.M. are shown, n=3. Representative images, scale bar is 10 μm. (D) Summary of live pups born as well as live embryos at E16.5 generated from Brca1+/CC x Brca1+/CC intercross. (E) Representative photographs of E16.5 embryos, scale bar 0.5 cm; and 3-week old littermates, scale bar 2 cm. Hypopigmented fur area is indicated with an arrow. (F) Weights of individual mice at 3–4 weeks of age. (G) White blood cell (WBC), red blood cell (RBC) numbers from peripheral blood, and (H) mononuclear bone marrow (BM) cell numbers were measured in 3–4-week-old littermates with the indicated genotypes. Inset, representative H&E staining of BM, scale bar 100 μm. (I) Total number of long-term hematopoietic stem cells (LT-HSC) (Linlow; cKit+; Sca+; CD150+; CD48−; CD34−) analyzed by FACS in 3–4-week-old mice. See Fig. S1 for more information. (J) Representative H&E staining of testes and ovaries, scale bar 100 μm. (K) Representative images of T-ALL from a Brca1CC/CC mouse. H&E staining of thymic tumor and CD3+ staining of tumor cell infiltrates from the same mouse, scale bar 100 μm. Summary of Brca1CC/CC lifespans (days) and cause of death when known (inset). *p < 0.05 **p < 0.01, *** p < 0.001 (unpaired t-test).

Journal: Molecular cell

Article Title: BRCA1 mutational complementation induces synthetic viability

doi: 10.1016/j.molcel.2020.04.006

Figure Lengend Snippet: (A) The Brca1CC allele was generated using the indicated sgRNA sequence that targeted exon 13. DNA and amino acids deleted are shown (red). Below, electropherogram showing DNA sequences of Brca1+/+ and Brca1CC/CC mice, deleted base pairs (box) and deletion location (arrow) are indicated. (B) MEFs with the indicated genotypes were assessed for Brca1 protein expression by Western blotting. (C) MEFs with the indicated genotypes were assessed for RAD51 IRIF by immunofluorescence (IF). Nuclei with >5 foci were considered positive. Mean and S.E.M. are shown, n=3. Representative images, scale bar is 10 μm. (D) Summary of live pups born as well as live embryos at E16.5 generated from Brca1+/CC x Brca1+/CC intercross. (E) Representative photographs of E16.5 embryos, scale bar 0.5 cm; and 3-week old littermates, scale bar 2 cm. Hypopigmented fur area is indicated with an arrow. (F) Weights of individual mice at 3–4 weeks of age. (G) White blood cell (WBC), red blood cell (RBC) numbers from peripheral blood, and (H) mononuclear bone marrow (BM) cell numbers were measured in 3–4-week-old littermates with the indicated genotypes. Inset, representative H&E staining of BM, scale bar 100 μm. (I) Total number of long-term hematopoietic stem cells (LT-HSC) (Linlow; cKit+; Sca+; CD150+; CD48−; CD34−) analyzed by FACS in 3–4-week-old mice. See Fig. S1 for more information. (J) Representative H&E staining of testes and ovaries, scale bar 100 μm. (K) Representative images of T-ALL from a Brca1CC/CC mouse. H&E staining of thymic tumor and CD3+ staining of tumor cell infiltrates from the same mouse, scale bar 100 μm. Summary of Brca1CC/CC lifespans (days) and cause of death when known (inset). *p < 0.05 **p < 0.01, *** p < 0.001 (unpaired t-test).

Article Snippet: Cells were then resuspended in 0.5 ml of F-PBS, counted, and incubated on ice for 60 minutes with the following antibodies: CD3 (145–2C11 Biolegend), CD4 (RM4–5 eBiosience), CD8 (53–6.7 eBioscience), CD19 (6D5 Biolegend), B220 (RA3–6B2 Biolegend), Gr1 (RB6–8C5 Biolegend), Ter119 (Ter119 Biolegend), cKit (2B8 BD, Pharmingen), Sca-1 (D7, eBioscience), CD150 (TC15–12F12.2 Biolegend), CD34 ( RAM34 BD Pharmingen), FcgRII/III (93 Biolegend), CD48 (HM48–1 Biolegend).

Techniques: Generated, Sequencing, Expressing, Western Blot, Immunofluorescence, Staining

KEY RESOURCES TABLE

Journal: Molecular cell

Article Title: BRCA1 mutational complementation induces synthetic viability

doi: 10.1016/j.molcel.2020.04.006

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Cells were then resuspended in 0.5 ml of F-PBS, counted, and incubated on ice for 60 minutes with the following antibodies: CD3 (145–2C11 Biolegend), CD4 (RM4–5 eBiosience), CD8 (53–6.7 eBioscience), CD19 (6D5 Biolegend), B220 (RA3–6B2 Biolegend), Gr1 (RB6–8C5 Biolegend), Ter119 (Ter119 Biolegend), cKit (2B8 BD, Pharmingen), Sca-1 (D7, eBioscience), CD150 (TC15–12F12.2 Biolegend), CD34 ( RAM34 BD Pharmingen), FcgRII/III (93 Biolegend), CD48 (HM48–1 Biolegend).

Techniques: Recombinant, Plasmid Preparation, Staining, Mutagenesis, Modification, Software

Leukocytes were isolated from Tbx21 +/+ (WT; blue) and Tbx21 -/- (red) bone marrow and iNK, mNK1 and mNK2 cell subsets were screened by flow cytometry for differentially expressed proteins. Proteins examined were selected based on differential expression of their transcripts between Tbx21 +/+ and Tbx21 -/- in the RNASeq screen. Representative histograms and summary graphs for (a) CCR2, (b) CD49a, (c) CD62L, (d) CD69, (e) CD127, (f) cKit, (g) CXCR6, (h) CX3CR1, and (i) S1PR5 are shown. n = 6 mice per group, means and SD are shown. Significance was determined using two-sample, one-tailed t tests with Holm-Sidak correction. * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: bioRxiv

Article Title: Tbet promotes NK cell egress from the bone marrow and CXCR6 expression in immature NK cells

doi: 10.1101/583575

Figure Lengend Snippet: Leukocytes were isolated from Tbx21 +/+ (WT; blue) and Tbx21 -/- (red) bone marrow and iNK, mNK1 and mNK2 cell subsets were screened by flow cytometry for differentially expressed proteins. Proteins examined were selected based on differential expression of their transcripts between Tbx21 +/+ and Tbx21 -/- in the RNASeq screen. Representative histograms and summary graphs for (a) CCR2, (b) CD49a, (c) CD62L, (d) CD69, (e) CD127, (f) cKit, (g) CXCR6, (h) CX3CR1, and (i) S1PR5 are shown. n = 6 mice per group, means and SD are shown. Significance was determined using two-sample, one-tailed t tests with Holm-Sidak correction. * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: The following anti-mouse antibodies were used: anti-CCR2-PE-Cyanine7 (clone SA203G11, Biolegend, London, UK), anti-CD3-FITC (17A2, Biolegend), anti-CD3-biotin (clone 145-2C11, Sony Biotechnology, Surrey, UK), anti-CD4-BV786 (clone RM4-5, BD Horizon), anti-CD8α-FITC (clone 53-6.7, Biolegend), anti-CD8α-biotin (clone 53-6, Sony), anti-CD11b-APC (clone M1/70, Biolegend), anti-CD11b-PE (clone M1/70, Biolegend), anti-CD11b-AlexaFluor700 (clone M1/70, BD Pharmingen), anti-CD19-FITC (clone 6D5, Biolegend), anti-CD19-PerCP-Cyanine5.5 (clone 6D5, Biolegend), anti-CD19-biotin (clone 6D5, Sony), anti-CD27-APC (clone LG.3A10, Biolegend), anti-CD27-APCeFluor780 (clone LG.7F9, eBioscience, San Diego, CA), anti-CD27-PE-Dazzle594 (clone LG.3A10, Biolegend), anti-CD27-APC-Cyanine7 (clone LG.7F9, eBio-science), anti-CD45-BV510 (clone 30-F11, Biolegend), anti-CD45-APC-Cyanine7 (clone 30-F11, BD Pharmingen), anti-CD45.2 PE-eFluor610 (clone 104, eBioscience), anti-CD45.1-PE-Cyanine7 (clone A20, Biolegend), anti-CD49a-BUV395 (clone Ha31/8, BD Bioscience), anti-CD49b-BV510 (clone HMα2, BD Optibuild), anti-CD62L-PerCP-Cyanine5.5 (clone MEL-14, Biolegend), anti-CD69-PerCP-Cyanine5.5 (clone H1.2F3, Biolegend), anti-CD117(cKit)-BV510 (clone 2B8, Biolegend), anti-CD117 (ckit)-APC-Cyanine7 (clone ACK2, Sony), anti-CD122 (IL-2Rβ)-eFluor450 (clone TM-β1, eBioscience), anti-CD122 (IL-2R-β)-APC (clone TM-β1, Biolegend), anti-CD127 (IL-7Rα)-PE (clone A7R34, eBioscience), anti-CD127 (IL-7Rα)-PE-Cyanine7 (clone A7R34, Sony), anti-CD135 (Flt3)-PerCP-eFluor710 (clone A2F10, eBioscience), anti-CD135 (Flt3)-PE (clone A2F10, Sony), anti-CD244.2-PE-Cyanine7 (clone m2B4 (B6)458.1, Biolegend), anti-CX3CR1-BV510 (clone SA011F11, Biolegend), anti-CXCR6-PE-Cyanine7 (clone SA051D1, Biolegend), anti-Gr-1-FITC (clone RB6-8C5, Biolegend), anti-Gr-1-APC (clone RB6-8C5, Biolegend), anti-GR1-biotin (clone RB6-8C5, BD Pharmingen), anti-integrin α4β7-BV421 (clone DATK32, BD Horizon), anti-NK1.1-FITC (clone PK136, Biolegend), anti-NK1.1-APC-eFluor780 (clone PK136, eBioscience), anti-NK1.1-BV650 (clone PK136, Sony), anti-NKp46-BV711 (clone 29A1.4, Biolegend), anti-NKp46-V450 (clone 29A1.4, BD Horizon), anti-Sca-1-AlexaFluor700 (clone D7, Biolegend), anti-Sca-1-BV510 (clone D7, Sony), anti-S1PR5-PE (clone 1196A, Bio-Techne, Abingdon, UK), anti-TCRαβ-biotin (clone H57 597, Sony), anti-TCRγδ-biotin (clone GL3, BD Pharmingen), anti-TER119-biotin (clone TER-119, Sony) and streptavidin-PE-Cyanine5 (BD Pharmingen) for surface antigens; and anti-Eomes-PE-Cyanine7 (clone Dan11mag, eBioscience) and anti-Tbet-eFluor660 (clone eBio4B10, eBioscience) for intracellular staining.

Techniques: Isolation, Flow Cytometry, Expressing, One-tailed Test